NDC62135-0495-01: GRISEOFULVIN TABLETS,ULTRAMICROS.
GRISEOFULVIN TABLETS,ULTRAMICROS. Key specifications include administration: ORAL, primary_container_type: BOTTLE, protective_storage_feature: CONTROLLED ROOM TEMPERATURE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-586-0607, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | GRISEOFULVIN TABLETS, ULTRAMICROSIZE, 250 MG; STORE AT CONTROLLED ROOM TEMPERATURE BETWEEN 15 AND 30 DEG C IN TIGHT, LIGHT-RESISTANT CONTAINERS; BOTTLE OF 100 TABLETS DEGC |
| primary_container_type | BOTTLE |
| protective_storage_feature | CONTROLLED ROOM TEMPERATURE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | GRISEOFULVIN TABLETS ULTRAMICROSIZE USP 250MG 100S |
| NSN | 6505-01-586-0607 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | GRISEOFULVIN TABLETS, ULTRAMICROSIZE, 250 MG; STORE AT CONTROLLED ROOM TEMPERATURE BETWEEN 15 AND 30 DEG C IN TIGHT, LIGHT-RESISTANT CONTAINERS; BOTTLE OF 100 TABLETS DEGC |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | GRISEOFULVIN TABLETS ULTRAMICROSIZE USP 250MG 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT |